Cataract volume is on track with expectations, while refractive volume is still low; glaucoma procedures are being driven by minimally invasive surgery; and retinal procedures are up 4.1 percent over Q4-2013 totals.
Protocol deviations and enrollment issues dominated the discussion.
Speakers expect significant technology innovation in the coming years.
Sales are forecast to total $412 million in 2015.
A decision is expected in late June or early July; it could affect HealthCare.gov enrollees in 34 states.
You are not currently logged in.
©2018 Market Scope
Lost your Password